我要投票 爱威在医疗器械行业中的票数:129
· 外 推 电 报 ·
2025-02-23 19:12:41 星期日

【爱威是哪个国家的品牌?】

爱威是什么牌子?「爱威」是 爱威科技股份有限公司 旗下著名品牌。该品牌发源于湖南省长沙市,由创始人丁 * 文在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力爱威品牌出海!通过在本页面挂载爱威品牌的产品链接和联系邮箱,可以提高爱威产品曝光!跨境电商爆单神器,目前只要100元/年哦~

爱威科技股份有限公司成立于2000年3月16日,总部位于湖南长沙高新技术产业开发区,是一家按照现代企业制度组建而成的专业从事医疗器械、实验仪器、体外诊断试剂与耗材、电子产品、远程医疗网络、计算机软件、自动控制设备、医疗辅助设备等产品的研究、开发、生产、销售及相关技术服务的现代企业。公司基于“创新驱动发展”战略,专注于临床医疗检验设备、体外诊断试剂及医用耗材的研发和产业化,自主创新研发的“医学显微镜形态学检验自动化”等多项关键共性技术处于国际出色地位。公司已成长为国内具国际竞争力的高性能医疗检验设备提供商,并于2015年2月在新三板挂牌上市(股票名称:爱威科技,股票代码:831895)。

爱威科技在国内外设立了两家全资子公司,其中湖南爱威医疗科技有限公司位于长沙岳麓区岳麓科技产业园,占地67亩,已建成高性能医疗器械及体外诊断试剂耗材研发与生产基地超过5万平方米;美国全资子公司AVETECH INC.(爱威科技(美国)有限公司)于2015年在美国马里兰州盖塞斯堡注册成立。

公司聚集了一批多学科领域的博士、硕士、本科等技术型人才,并承担了医学显微镜检验自动化湖南省工程研究中心等省部级工程研究中心的建设。公司专注于智能医学检验关键技术和相关医疗设备研发,尤其在自动显微镜形态学检验领域,形成了以国际前沿的“机器视觉技术”和“智能显微镜形态学检验技术”为核心的重大科技成果,实现了临床尿液、血液、粪便、体液等标本中有形病理成分显微图像高速可视,智能识别分类和定量计数,终结了显微镜检查只能依靠人工完成的历史。目前公司在全国30个省级行政区设立了办事机构,产品在国内装机用户已超过4000家;在国际上,产品已出口到欧洲、美洲、亚洲等国家和地区。

公司将继续秉承“科技服务健康”的核心理念,以“创造成果,实现价值,共同发展”为经营宗旨,通过自主研发和整合国际国内出色技术,采用专业的生产工艺,专注于医疗器械、实验仪器和体外诊断试剂、耗材等的研究、开发和产业化,使公司成长为国际、国内受人尊重的高性能医疗器械研发、制造和医疗健康服务行业的标杆企业,为实现“让老百姓都能享受现代医疗健康服务”的美好愿景而努力奋斗。


英文翻译:Founded on March 16, 2000 and headquartered in Changsha hi tech Industrial Development Zone, Hunan Province, AVIC Technology Co., Ltd. is a company established in accordance with the modern enterprise system, specializing in the research and development of medical devices, experimental instruments, in vitro diagnostic reagents and consumables, electronic products, telemedicine network, computer software, automatic control equipment, medical auxiliary equipment and other products A modern enterprise engaged in development, production, sales and related technical services. Based on the strategy of "innovation driven development", the company focuses on the R & D and industrialization of clinical medical testing equipment, in vitro diagnostic reagents and medical consumables, and many key generic technologies such as "medical microscope Morphology Test Automation" independently innovated and developed are in an outstanding position in the world. The company has grown into a high-performance medical inspection equipment provider with international competitiveness, and was listed on the new third board in February 2015 (Stock Name: AVIC technology, stock code: 831895). AVIC technology has set up two wholly-owned subsidiaries at home and abroad, of which Hunan AVIC Medical Technology Co., Ltd. is located in Yuelu science and Technology Industrial Park, Yuelu District, Changsha, covering an area of 67 mu, and has built a research and development and production base of high-performance medical devices and in vitro diagnostic reagent consumables of more than 50000 square meters; avetech Inc., a wholly-owned subsidiary of AVIC Technology (America) Co., Ltd., was in the United States in 2015 Gaicesburg, Maryland. The company has gathered a number of multi-disciplinary technical talents such as doctors, masters and undergraduates, and has undertaken the construction of provincial and ministerial engineering research centers such as Hunan Engineering Research Center of medical microscope inspection automation. The company focuses on the research and development of key technologies of intelligent medical examination and related medical equipment, especially in the field of automatic microscopic morphology examination. It has formed major scientific and technological achievements with the international cutting-edge "machine vision technology" and "intelligent microscopic morphology examination technology" as the core, realizing the high-speed microscopic image of tangible pathological components in clinical urine, blood, feces, body fluids and other specimens Visual, intelligent recognition, classification and quantitative counting have ended the history that microscopy can only be done by human. At present, the company has set up offices in 30 provincial administrative regions, with more than 4000 domestic installed users. Internationally, the products have been exported to Europe, America, Asia and other countries and regions. The company will continue to adhere to the core concept of "science and technology serve health", with the business purpose of "creating achievements, realizing value and common development", through independent research and development and integration of international and domestic excellent technology, adopting professional production technology, focusing on the research, development and industrialization of medical devices, experimental instruments, in vitro diagnostic reagents, consumables, etc., so that the company can grow into an international and national company The high-performance medical device R & D, manufacturing and medical and health service industry benchmarking enterprises that are respected by the people strive to realize the good vision of "let people enjoy modern medical and health services".

本文链接: https://www.waitui.com/brand/f8296e44c.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

天岳先进:2024年净利润1.8亿元 同比扭亏为盈

36氪获悉,天岳先进发布业绩快报,公司2024年实现营业收入17.68亿元,同比增长41.37%;实现归属于母公司所有者的净利润1.80亿元,同比扭亏为盈。主要原因是公司大尺寸、导电型产品产能产量持续提升,销售量增加,同时产品毛利率上升。

2小时前

小米集团卢伟冰:小米15 Ultra会是越级式的一代产品

36氪获悉,小米集团合伙人兼总裁、手机部总裁、小米品牌总经理卢伟冰发文称,小米手机未来5年高端化的目标之一,就是要在6000元+价格段实现规模化的突破,“Ultra是6K+突破的关键产品,而小米15 Ultra会是越级式的一代产品”。

2小时前

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

2小时前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

2小时前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

本页详细列出关于海氏海诺的品牌信息,含品牌所属公司介绍,海氏海诺所处行业的品牌地位及优势。
咨询